The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen […]
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an […]
A judge that rejected a bid by Sanofi-Aventis for an injunction blocking rival Alphapharm from listing an insulin injector pen on the PBS erred in […]
An Australian partner of international law firm Jones Day has moved to the firm’s Singapore office to bolster its growing team of international arbitration specialists. […]
International law firm Jones Day has expanded its intellectual property team in Sydney, hiring experienced patent litigator Andrew Rankine from Ashurst as its second local […]
The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin […]
From a record-setting funder’s cut to the first call for “proportionality”, last year saw a number of groundbreaking judgments approving class action settlements worth more […]
French pharmaceutical giant Sanofi has appealed a judge’s ruling denying its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme. […]
A barrister for two units of embattled wealth manager IOOF and three senior company executives facing claims by APRA have criticised the regulator for filing […]
A judge has denied Sanofi’s bid to block Alphapharm from listing its insulin injector pen on the Pharmaceutical Benefit Scheme, saying Sanofi has not established […]